SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-20-000169
Filing Date
2020-06-16
Accepted
2020-06-16 09:01:43
Documents
8
Period of Report
2020-06-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnbt061620form8k.htm 8-K 31321
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 4085
3 GRAPHIC image_005.gif GRAPHIC 4901
4 GRAPHIC image_001.jpg GRAPHIC 631
5 GRAPHIC image_004.gif GRAPHIC 1579
6 GRAPHIC image_007.gif GRAPHIC 4157
7 GRAPHIC image_001.gif GRAPHIC 1667
8 GRAPHIC image_006.gif GRAPHIC 4157
  Complete submission text file 0001607062-20-000169.txt   60280
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-25169 | Film No.: 20965092
SIC: 2834 Pharmaceutical Preparations